PNPLA3 and metabolic dysfunction-associated steatotic liver disease: The genetic component of MASLD was largely revealed in the 2008 landmark genome-wide association of the Dallas Heart Study cohort by Romeo et al., which identified significant association of the Ile148Met (I148M) variant of PNPLA3 that was associated with MASLD [74].